When the Gold Standard Feels Out of Reach: Rethinking ADHD Treatment in 2025
By Lindsay Fuson, FNP-C, PMHNP-BC | Wellbeing NP For decades, stimulant medications like Adderall and Vyvanse have been considered the gold standard in treating Attention-Deficit/Hyperactivity Disorder (ADHD). And for good reason — research consistently shows that when properly prescribed, stimulants reduce core symptoms like inattention, impulsivity, and executive dysfunction in up to 70–80% of patients. […]